Mazzo Details Plans For Kamra Inlay’s Introduction To The US Following FDA Approval

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 037″] Chairman and CEO Jim Mazzo tells how the AcuFocus team went above and beyond to share news of Kamra’s FDA approval at ASCRS, looks forward to US launch. Podcast Guest Jim Mazzo Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known…

Read More

PowerVision’s Cheskin Discusses The Potential Of The Company’s Accommodating IOL, FluidVision

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 035″] For 10 years PowerVision has been advancing its accommodating IOL, Flu-idVision. Co-Founder, CEO and President Barry Cheskin explains how the company has kept its focus on someday capturing a huge piece of the IOL market. Podcast Guest Barry Cheskin Barry Cheskin is Co-Founder, President & CEO of PowerVision. Mr. Cheskin…

Read More

Holland Delivers Overview Of ASCRS, Ophthalmology

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 031″] ASCRS Program Chair Ed Holland Talks ASCRS Meeting, Technology and Ophthalmology: The Next Generation. Podcast Guest Edward Holland, MD Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Clinical Ophthalmology at the University of Cincinnati. He has been awarded the Castroviejo Award from the…

Read More

Alcon’s Plan For WaveTec’s ORA System

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 028″] Alcon’s Warner, Tom Frinzi Discuss the WaveTec Vision Acquisition Details. Podcast Guest Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. Prior to joining Abbott, Mr. Frinzi held a…

Read More

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

Laurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the Ora System’s potential. Also, Attias adds his insights on the fascinating joint venture between Alcon and Google to develop a next generation contact lens. Speaking With: Laurent Attias Laurent Attias…

Read More

Avedro

Avedro’s KXL® System for accelerated cross-linking, as well as a family of riboflavin products, have been commercially available since 2010. Refractive correction pioneer and veteran David Muller, PhD, President & CEO, discussed the company’s most recent activities, expressing excitement about Avedro’s PiXL, a non-invasive refractive correction procedure, which uses only eye drops and light. Among other…

Read More

Opening The Door For Premium IOLs

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 017″] OIS stalwart Jack Holladay, MD shares details on the work of a task force comprised of representatives from the American Academy of Ophthalmology and the Food and Drug Administration charged with updating the regulatory agency’s Grid and developing a Guidance Document for Extended Depth of Focus and Accommodating IOLs. The…

Read More

Alcon’s George Shares Passion for Ophthalmology

Chicago— Jeff George, Global Head of Alcon Inc., introduced himself to the Ophthalmology Innovation Summit community with a far-ranging keynote address, “Accelerating Innovation in Ophthalmology.” Appointed to lead Alcon in May 2014, George — who had been an executive at Alcon’s parent company, Novartis — revealed that as a youngster he had very high myopia.…

Read More

Mobius Therapeutics Investigates Extending Mitosol Platform

Ed Timm, President and CEO of Mobius Therapeutics LLC, provided an update on the investigations into extending the company’s Mitosol platform, presently used to administer mitomycin-C in ab externo glaucoma surgery. Mitosol avoids the issues of sterility and stability of mitomycin-C made in compounding pharmacies. Mobius is investigating the use of the platform in refractive…

Read More

Slade Discusses The Opportunities, And Challenges, Of New Technology

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 008″] Throughout his career, Stephen Slade, MD, has been an early adopter of new ophthalmic technologies, being among the first to use LASIK, and femtosecond lasers in cataract removal. As a seasoned early adopter, Slade expresses some reservations around new “back-office” technologies in his practice – namely EMRs. Despite these concerns,…

Read More

Hear How Avedro’s Muller Is Building A Cross-Linking Powerhouse

OIS Podcast

Episode 007 CEO David Muller, maps out Avedro’s designs to dominate the corneal cross-linking market and potentially change the game of vision correction. Podcast Guest David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO. Under…

Read More

ClarVista Medical

Paul McLean updates us on the progress of the HARMONI™ Modular IOL and its first-in-human clinical study. Presenter: Paul McLean Paul McLean is President and CEO of ClarVista Medical. ClarVista Medical is clinical stage, ophthalmic device Start-up Company focused on the development of the HARMONI modular intra-ocular lens system to optimize vision in the setting…

Read More